| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.1M | — | +5.2% |
| Cost of Revenue | $4.8M | — | +14.3% |
| Gross Profit | $4.3M | — | -3.5% |
| R&D Expense | $694K | — | +3.7% |
| SG&A Expense | $2.2M | — | -8.3% |
| Operating Income | $787K | — | +512.1% |
| Pre-tax Income | $582K | — | +130.0% |
| Income Tax | $68K | — | -4.8% |
| Net Income | $515K | — | +125.6% |
| EPS (Basic) | $0.04 | — | +123.5% |
| EPS (Diluted) | -$0.04 | — | -123.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $6.1M | -5.2% | +15.1% |
| Inventory | $479K | +1.1% | -41.1% |
| Current Assets | $10.5M | -7.9% | +1.8% |
| Total Assets | $39.7M | -1.6% | +5.1% |
| Current Liabilities | $8.3M | -3.2% | +41.5% |
| Long-term Debt | $42.7M | +0.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.0M | — | +577.2% |
| Investing Cash Flow | -$1.5M | — | -643.2% |
| Financing Cash Flow | -$59K | — | +8.1% |
| +0.2% |
| Total Liabilities | $51.5M | -0.6% | +4.7% |
| Stockholders' Equity | -$11.9M | -2.8% | -3.6% |